Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Pigment Epithelium | 8 | 2016 | 301 | 1.550 |
Why?
|
Blood-Retinal Barrier | 4 | 2016 | 62 | 1.120 |
Why?
|
Uveomeningoencephalitic Syndrome | 1 | 2023 | 22 | 0.860 |
Why?
|
Vascular Endothelial Growth Factor A | 7 | 2018 | 3480 | 0.640 |
Why?
|
Retinal Hemorrhage | 1 | 2018 | 95 | 0.610 |
Why?
|
Polyps | 1 | 2018 | 197 | 0.560 |
Why?
|
Choroid | 1 | 2018 | 350 | 0.530 |
Why?
|
Choroidal Neovascularization | 2 | 2018 | 357 | 0.510 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.510 |
Why?
|
Macular Edema | 2 | 2016 | 374 | 0.470 |
Why?
|
Ophthalmology | 1 | 2021 | 549 | 0.470 |
Why?
|
Retinal Diseases | 1 | 2020 | 702 | 0.440 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2012 | 18 | 0.430 |
Why?
|
Retina | 3 | 2020 | 2637 | 0.420 |
Why?
|
Papilledema | 1 | 2014 | 130 | 0.420 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 544 | 0.410 |
Why?
|
Tomography, Optical Coherence | 8 | 2022 | 2880 | 0.350 |
Why?
|
Antirheumatic Agents | 1 | 2020 | 1368 | 0.340 |
Why?
|
Retinal Perforations | 2 | 2022 | 138 | 0.330 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2548 | 0.270 |
Why?
|
Electroretinography | 5 | 2020 | 517 | 0.250 |
Why?
|
Retinal Degeneration | 3 | 2014 | 412 | 0.250 |
Why?
|
Fluorescein Angiography | 4 | 2022 | 1043 | 0.250 |
Why?
|
Fundus Oculi | 4 | 2022 | 541 | 0.210 |
Why?
|
Vision, Monocular | 1 | 2022 | 71 | 0.200 |
Why?
|
Iridocyclitis | 1 | 2021 | 11 | 0.200 |
Why?
|
Uveitis, Intermediate | 1 | 2021 | 17 | 0.190 |
Why?
|
Serum Albumin | 2 | 2015 | 672 | 0.180 |
Why?
|
Vision, Binocular | 1 | 2022 | 225 | 0.180 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2014 | 772 | 0.180 |
Why?
|
Intravitreal Injections | 2 | 2018 | 384 | 0.170 |
Why?
|
Endotamponade | 1 | 2019 | 37 | 0.160 |
Why?
|
Eye | 1 | 2023 | 710 | 0.160 |
Why?
|
Epiretinal Membrane | 1 | 2019 | 73 | 0.160 |
Why?
|
Rabbits | 2 | 2015 | 4772 | 0.150 |
Why?
|
Uveitis | 1 | 2021 | 393 | 0.150 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2020 | 250 | 0.140 |
Why?
|
Visual Field Tests | 1 | 2020 | 411 | 0.140 |
Why?
|
Reperfusion Injury | 2 | 2014 | 1023 | 0.140 |
Why?
|
Indocyanine Green | 1 | 2018 | 232 | 0.140 |
Why?
|
Retinoids | 2 | 2014 | 98 | 0.130 |
Why?
|
Coloring Agents | 1 | 2018 | 559 | 0.130 |
Why?
|
Vitrectomy | 1 | 2019 | 391 | 0.130 |
Why?
|
Immunoblotting | 2 | 2016 | 1647 | 0.120 |
Why?
|
Lipofuscin | 1 | 2013 | 40 | 0.110 |
Why?
|
Histone Deacetylase 2 | 1 | 2013 | 72 | 0.110 |
Why?
|
Ocular Hypertension | 1 | 2014 | 206 | 0.110 |
Why?
|
Visual Fields | 1 | 2020 | 1054 | 0.110 |
Why?
|
Visual Acuity | 2 | 2019 | 2642 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 728 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2015 | 18114 | 0.100 |
Why?
|
Complement Membrane Attack Complex | 1 | 2012 | 105 | 0.100 |
Why?
|
Atrial Natriuretic Factor | 1 | 2012 | 350 | 0.100 |
Why?
|
Blotting, Western | 3 | 2014 | 5031 | 0.100 |
Why?
|
Retinal Ganglion Cells | 2 | 2014 | 806 | 0.100 |
Why?
|
Cyclic GMP | 1 | 2012 | 395 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2018 | 2047 | 0.090 |
Why?
|
Rats, Inbred BN | 3 | 2016 | 231 | 0.090 |
Why?
|
Cadaver | 1 | 2015 | 1345 | 0.090 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2016 | 1110 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2014 | 718 | 0.080 |
Why?
|
Lysine | 1 | 2014 | 993 | 0.080 |
Why?
|
Biological Assay | 1 | 2011 | 626 | 0.080 |
Why?
|
Intraocular Pressure | 1 | 2014 | 1288 | 0.080 |
Why?
|
Cyclic AMP | 1 | 2012 | 1455 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2469 | 0.080 |
Why?
|
Macular Degeneration | 2 | 2014 | 1001 | 0.070 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3152 | 0.070 |
Why?
|
Hyperglycemia | 1 | 2016 | 1368 | 0.070 |
Why?
|
Immunohistochemistry | 3 | 2016 | 11063 | 0.070 |
Why?
|
Diabetic Retinopathy | 1 | 2016 | 1267 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4220 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3799 | 0.060 |
Why?
|
Histones | 1 | 2014 | 2570 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2012 | 1704 | 0.060 |
Why?
|
Humans | 13 | 2023 | 757566 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2016 | 18936 | 0.050 |
Why?
|
Valproic Acid | 2 | 2014 | 442 | 0.050 |
Why?
|
Acetylation | 2 | 2014 | 1057 | 0.050 |
Why?
|
Cell Line | 2 | 2012 | 15587 | 0.050 |
Why?
|
Hydroxamic Acids | 2 | 2014 | 481 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13952 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2011 | 3664 | 0.040 |
Why?
|
Animals | 7 | 2016 | 167718 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 219192 | 0.040 |
Why?
|
Male | 6 | 2023 | 358180 | 0.040 |
Why?
|
International Classification of Diseases | 1 | 2021 | 891 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8654 | 0.030 |
Why?
|
Retinal Neurons | 1 | 2014 | 66 | 0.030 |
Why?
|
Acetyltransferases | 1 | 2014 | 231 | 0.030 |
Why?
|
Pyridinium Compounds | 1 | 2013 | 81 | 0.030 |
Why?
|
Rhodopsin | 1 | 2014 | 203 | 0.030 |
Why?
|
Signal Transduction | 2 | 2014 | 23335 | 0.030 |
Why?
|
Retinaldehyde | 1 | 2011 | 24 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2014 | 3102 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 507 | 0.020 |
Why?
|
Vision, Ocular | 1 | 2014 | 454 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2014 | 2558 | 0.020 |
Why?
|
Chronic Disease | 2 | 2016 | 9263 | 0.020 |
Why?
|
Retinal Vessels | 1 | 2016 | 836 | 0.020 |
Why?
|
Serpins | 1 | 2011 | 247 | 0.020 |
Why?
|
Rats | 2 | 2016 | 23676 | 0.020 |
Why?
|
Tight Junctions | 1 | 2011 | 317 | 0.020 |
Why?
|
Nerve Growth Factors | 1 | 2011 | 562 | 0.020 |
Why?
|
Tretinoin | 1 | 2011 | 519 | 0.020 |
Why?
|
Complement System Proteins | 1 | 2012 | 782 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2011 | 1094 | 0.020 |
Why?
|
Eye Proteins | 1 | 2011 | 633 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 956 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2014 | 21990 | 0.020 |
Why?
|
Fetus | 1 | 2012 | 1860 | 0.010 |
Why?
|
Viral Proteins | 1 | 2011 | 1803 | 0.010 |
Why?
|
Cell Survival | 1 | 2014 | 5781 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4760 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2014 | 3709 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2127 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5325 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9514 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58558 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22022 | 0.010 |
Why?
|
Female | 4 | 2022 | 389943 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 87819 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14345 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39020 | 0.010 |
Why?
|
Mice | 2 | 2014 | 81066 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11890 | 0.010 |
Why?
|
Aged | 2 | 2019 | 167890 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2013 | 26176 | 0.010 |
Why?
|
Adult | 2 | 2019 | 219725 | 0.010 |
Why?
|
Infant | 1 | 2013 | 36045 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42045 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 79984 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2011 | 13597 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 58755 | 0.000 |
Why?
|
Child | 1 | 2013 | 79782 | 0.000 |
Why?
|
Concepts
(135)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(13)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_